A Dual-Antigen SARS-CoV-2 Serological Assay Reflects Antibody Avidity

J Clin Microbiol. 2022 Feb 16;60(2):e0226221. doi: 10.1128/JCM.02262-21. Epub 2021 Dec 1.

Authors

Yu Nakagama^{1

2}, Yuko Nitahara^{1

2}, Natsuko Kaku^{1

2}, Evariste Tshibangu-Kabamba^{1

2}, Yasutoshi Kido^{1

2}

Affiliations

¹ Department of Parasitology, Osaka City Universitygrid.261445.0, Osaka, Japan.
² Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka City Universitygrid.261445.0, Osaka, Japan.

No abstract available

Keywords: COVID-19; SARS-CoV-2; avidity maturation; serological assay.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Viral
Antibody Affinity
COVID-19*
Humans
Immunoglobulin M
SARS-CoV-2*
Sensitivity and Specificity

Substances

Antibodies, Viral
Immunoglobulin M

Grants and funding